Cleared Traditional

K252251 - EASYMADE-TI

K252251 is an FDA 510(k) clearance for EASYMADE-TI, manufactured by CG Bio Co., Ltd.. The device is a Class 2 Neurology device with product code GXN cleared through the Traditional 510(k) pathway after a 265-day FDA review.

K252251 · CG Bio Co., Ltd. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2026
Decision
265d
Days
Class 2
Risk

K252251 is an FDA 510(k) clearance for the EASYMADE-TI. Classified as Plate, Cranioplasty, Preformed, Non-alterable (product code GXN), Class II - Special Controls.

Submitted by CG Bio Co., Ltd. (Seoul, KR). The FDA issued a Cleared decision on April 9, 2026 after a review of 265 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5330 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all CG Bio Co., Ltd. devices

FDA 510(k) Submission Details - K252251

510(k) Number K252251 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 2025
Decision Date April 09, 2026
Days to Decision 265 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
117d slower than avg
Panel avg: 148d · This submission: 265d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GXN Device Classification - Class 2, Special Controls

Product Code GXN Plate, Cranioplasty, Preformed, Non-alterable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GXN Plate, Cranioplasty, Preformed, Non-alterable

All 54
Devices cleared under the same product code (GXN) and FDA review panel - the closest regulatory comparables to K252251.
ClearFit Ti Ring 14mm (171750)
K260709 · Longeviti Neuro Solutions · Jun 2026
3D MAC Titanium Cranial Plate (TCP) System
K253116 · The Surgeon General, Department of the Army (TSG-DA) · Jun 2026
METICULY Patient-specific titanium mesh implant
K252958 · Meticuly Co., Ltd. · Jan 2026
Synthes Patient Specific Implants
K243715 · Synthes GmbH · Nov 2025
KLS Martin Cranial Implants - MR Conditional
K252573 · KLS-Martin L.P. · Nov 2025
CustomizedBone Service
K240567 · Fin-Ceramica Faenza S.P.A. · Mar 2024